| 1Trastuzumab mc-PAB-MMAF Cysteine Conjugate |
|---|
Analyte not found
Applications
Average DAR for Trastuzumab mcMMAF Cysteine Conjugate
24736
Separation Mode: Reversed Phase
Reversed Phase
Intact XB-C8
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 24736)
Column: | ||||||||||||||||||||||||||||||||||||||||
Brand Name: | ||||||||||||||||||||||||||||||||||||||||
Part No: | ||||||||||||||||||||||||||||||||||||||||
Phase Name: Intact XB-C8 | ||||||||||||||||||||||||||||||||||||||||
Elution Type: Gradient | ||||||||||||||||||||||||||||||||||||||||
Mobile Phase: A: 0.1% TFA in Water B: 0.1% TFA in ACN | ||||||||||||||||||||||||||||||||||||||||
Gradient Profile:
| ||||||||||||||||||||||||||||||||||||||||
Flow Rate: 0.4 mL/min | ||||||||||||||||||||||||||||||||||||||||
Temperature: 22°C | ||||||||||||||||||||||||||||||||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 280 NM (22°C) |
Order Items Used in This Application
00F-4766-AN
bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea
Qty:
Similar Applications
search
Trastuzumab mc-PAB-MMAF Cysteine Conjugate
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
